As per the research report titled ‘Global Minimally Invasive Thoracic Surgery Market Size study, By Type (Lobectomy, Wedge Resection, Pneumonectomy) and Regional Forecasts, 2021-2027’’ available with MarketStudyReport, global minimally invasive thoracic surgery market is expected to reach USD 4.1 billion by 2027 from USD 2.3 billion in 2020, registering a CAGR of 8.7% during the study period.
 

The multiplying cases of chronic diseases and shifting preferences towards minimally invasive procedure are majorly driving the growth of global minimally invasive thoracic surgery market. Simultaneously, rapid technological advancements and new product launches are also aiding towards the market expansion.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4566267/
 

For the record, minimally invasive thoracic surgery is a type of surgery that involves making small incisions in the body rather than massive cuts. Despite the positive outlook, high surgery costs are likely to hinder the market expansion over the study period.
 

The report offers a broad perspective of the various growth factors, challenges, and restraints that are defining the growth trajectory of this marketplace over the period of 2021-2027. It also offers granular analysis of the market segmentations including by type and regional reach.
 

By type, the industry is divided into pneumonectomy, wedge resection, and lobectomy segments.
 

Considering the geographical analysis, the report claimed that the North America market is expected to record considerable growth during the study period primarily because of unmet patient needs, innovative product launches, and availability of skilled experts.
 

Additional factors such as increased disposable income, growing lung cancer incidence, and mounting cigarette consumption is also favoring the regional market outlook. 
 

The major companies operating in global minimally invasive thoracic surgery market are Sklar Corporation, LivaNova plc, Medela Healthcare, Teleflex Inc., Dextera Surgical Inc., Grena Ltd., Richard Wolf GmbH, Intuitive Surgical Inc., Cardiomedical GmbH, and Medtronic plc. 
 

These companies are focusing on R&D activities, innovative product launches, and strategic collaborations to acquire a competitive lead in this business domain.